ClinicalTrials.gg
CompletedNCT05834179Updated Sep 11, 2025

Effect of Colding of Endotracheal Tubes on Sore Throat

An interventional study of cold endotracheal tube in Postoperative Sore Throat, sponsored by Baskent University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-11.

Primary conditionPharyngitis(the registry's first term)UnverifiedIs this wrong?The registry often attaches Pharyngitis to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Baskent University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
116
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Postoperative sore throat (POST) is a common and undesirable postoperative symptom that causes patient dissatisfaction. Cold application is a non-invasive, non-pharmacological, cost-effective and effort-effective therapy for pain management. The aim of this study was to evaluate whether colding of ETT can reduce sore throat, dysphagia and dysphonia after endotracheal intubation.

Read the detailed description

The incidence of postoperative sore throat (POST) has been reported up to 62% following general anaesthesia.It is an undesirable events experienced by patients after general anaesthesia. Various pharmacological agents have been applied to reduce POST, such as lidocaine, ketamine, magnesium, corticosteroids or non-steroidal anti-inflammatory drugs. However, these agents may have some systemic and local side effects. Therefore, various non-pharmacological applications have been investigated to reduce sore throat. Cold application is a non-invasive, cost-effective and effort-effective therapy for pain management. Although the mechanism is not clearly known, it increases the pain threshold, slows cellular metabolism, causes vasoconstriction, and reduces capillary permeability. Therefore, we hypothesized that colding of endotracheal tube may decrease POST associated with airway inflammation. The aim of this study was to evaluate whether colding of ETT can reduce sore throat, dysphagia and dysphonia after endotracheal intubation. The goal of this study is to identify a simple, safe, and inexpensive perioperative intervention to reduce post operative sore throat. This study is a prospective, randomised study involving 116 subjects and they will assessed on the incidence and severity of sore throat, dysphagia and dysphonia at 1. 4. 12. 24. hours after removal of endotracheal tube. Outcomes from this study can be extended to patients who will be receiving general anaesthesia using a endotracheal tube to reduce the incidence and severity of sore throat.

02

Conditions studied

  • Postoperative Sore Throat

Browse trials for

Keywords

  • endotracheal tube
  • sore throat
  • dysphagia
03

In context

Pharyngitis Unverified

226 studies on the registry are indexed under Pharyngitis; 35 are open to participants now.

This study's enrollment of 116 is below the median of 144 across 188 interventional studies indexed under Pharyngitis.

Browse Pharyngitis studies →

Lead sponsor

Baskent University is the lead sponsor of 209 studies on the registry; 35 are open to participants now.

Compared within Pharyngitis, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients who were entubated with an ETT. Those who accept the research Elective surgery Patients in American Society of Anaesthesiologists (ASA) I and II class 18 years and over Mallampati classification I and II Operation time more than 1 hour

Exclusion criteria

Exclusion Criteria:

Patients with sore throat and lower respiratory tract infection Patients with a history of allergies

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
116 participants (actual)

Study arms

  • Experimental
    cold endotracheal tube (ETT)

    Patients who were intubated with an ETT which kept in the fridge.

    Other: cold endotracheal tube

  • No intervention
    Endotracheal tube (ETT) in the normal temperature

    Patients who were intubated with an ETT which kept in the operation room.

Interventions

  • Othercold endotracheal tube

    patients who were intubated with an ETT which kept in the fridge.

06

What researchers measure

Primary outcomes

  1. the incidence of sore throat 1 hour after extubation.

    Presence of sore throat defined as constant pain, independent of swallowing (0=no. 1=yes)

    Time frame: 1 hour after extubation

Secondary outcomes

  1. the severity of sore throat 1 hour after extubation.

    Severity will be graded by the patient as 0=null; 1=mild; 2=moderate; 3=severe

    Time frame: 1 hour after extubation

  2. the incidence of sore throat 4 hour after extubation.

    Presence of sore throat defined as constant pain, independent of swallowing (0=no. 1=yes)

    Time frame: 4 hour after extubation

  3. the severity of sore throat 4 hour after extubation.

    Severity will be graded by the patient as 0=null; 1=mild; 2=moderate; 3=severe

    Time frame: 4 hour after extubation

  4. the incidence of sore throat 12 hour after extubation.

    Presence of sore throat defined as constant pain, independent of swallowing (0=no. 1=yes)

    Time frame: 12 hour after extubation

  5. the severity of sore throat 12 hour after extubation.

    Severity will be graded by the patient as 0=null; 1=mild; 2=moderate; 3=severe

    Time frame: 12 hour after extubation

  6. the incidence of sore throat 24 hour after extubation.

    Presence of sore throat defined as constant pain, independent of swallowing (0=no. 1=yes)

    Time frame: 24 hour after extubation

  7. the severity of sore throat 24 hour after extubation.

    Severity will be graded by the patient as 0=null; 1=mild; 2=moderate; 3=severe

    Time frame: 24 hour after extubation

  8. the incidence of dysphonia

    Presence of dysphonia defined as difficulty or pain on speaking (0=no. 1=yes)

    Time frame: 1 hour after extubation

  9. the incidence of dysphonia

    Presence of dysphonia defined as difficulty or pain on speaking (0=no. 1=yes)

    Time frame: 4 hour after extubation

  10. the incidence of dysphonia

    Presence of dysphonia defined as difficulty or pain on speaking (0=no. 1=yes)

    Time frame: 12 hour after extubation

  11. the incidence of dysphonia

    Presence of dysphonia defined as difficulty or pain on speaking (0=no. 1=yes)

    Time frame: 24 hour after extubation

  12. the incidence of dysphagia

    Presence of dysphagia defined as difficulty or pain provoked by swallowing

    Time frame: 12 hour after extubation

  13. the incidence of dysphagia

    Presence of dysphagia defined as difficulty or pain provoked by swallowing

    Time frame: 24 hour after extubation

  14. the incidence of postoperative respiratory infection

    Presence of respiratory infection symptoms such as cough, sputum, rhinorrhea, sore tongue, myalgia or fever

    Time frame: 7 days after operation

07

Study locations

1 site
  • Baskent University
    Adana, Adana, Turkey (Türkiye)
08

References and documents

Publications

  • Yu JH, Paik HS, Ryu HG, Lee H. Effects of thermal softening of endotracheal tubes on postoperative sore throat: A randomized double-blinded trial. Acta Anaesthesiol Scand. 2021 Feb;65(2):213-219. doi: 10.1111/aas.13705. Epub 2020 Sep 23. PubMed 32926423 ↗
  • Kim E, Yang SM, Kwak SG, Park S, Bahk JH, Seo JH. Tracheal tubes lubricated with water to reduce sore throat after intubation: A randomized non-inferiority trial. PLoS One. 2018 Oct 4;13(10):e0204846. doi: 10.1371/journal.pone.0204846. eCollection 2018. PubMed 30286145 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05834179
Lead sponsor
Baskent University
Responsible party
Sibel Catalca (Principal Investigator, Baskent University) — Principal investigator
First posted
Apr 28, 2023
Start date
Apr 15, 2023
Primary completion
Sep 15, 2023
Completion
Sep 20, 2023
Last update
Sep 11, 2025

Study contacts

sibel çatalca, dr.
principal investigator · Baskent University Ankara Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion